Drug Shortage Report for ACT ENALAPRIL

Last updated on 2017-10-10 History
Report ID 20326
Drug Identification Number 02291908
Brand name ACT ENALAPRIL
Common or Proper name ENALAPRIL
Company Name TEVA CANADA LIMITED
Active Ingredient(s) ENALAPRIL SODIUM
Strength(s) 16MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-20
Estimated end date 2017-09-15
Actual end date 2017-10-06
Shortage status Resolved
Updated date 2017-10-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2017-10-10 French Compare
v3 2017-10-10 English Compare
v2 2017-08-24 French Compare
v1 2017-08-24 English Compare